Global Safety Pharmacology
Novartis Institutes for Biomedical Research
Dr. Bernard Fermini is affiliated to Global Safety Pharmacology, Novartis Institutes for Biomedical Research. Dr. Bernard Fermini is currently providing services as Professor. Dr. Bernard Fermini has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Bernard Fermini contributions have acclaimed recognition from honourable subject experts around the world. Dr. Bernard Fermini is actively associated with different societies and academies. Dr. Bernard Fermini academic career is decorated with several reputed awards and funding. Dr. Bernard Fermini research interests include Global Safety Pharmacology.
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.